Precision Biosciences Stock Alpha and Beta Analysis
| DTIL Stock | USD 9.82 0.41 4.01% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Precision BioSciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Precision BioSciences over a specified time horizon. Remember, high Precision BioSciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Precision BioSciences' market risk premium analysis include:
Beta 0.26 | Alpha 0.0409 | Risk 7.01 | Sharpe Ratio 0.0135 | Expected Return 0.0943 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Precision |
Precision BioSciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Precision BioSciences market risk premium is the additional return an investor will receive from holding Precision BioSciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Precision BioSciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Precision BioSciences' performance over market.| α | 0.04 | β | 0.26 |
Precision BioSciences expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Precision BioSciences' Buy-and-hold return. Our buy-and-hold chart shows how Precision BioSciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Precision BioSciences Market Price Analysis
Market price analysis indicators help investors to evaluate how Precision BioSciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Precision BioSciences shares will generate the highest return on investment. By understating and applying Precision BioSciences stock market price indicators, traders can identify Precision BioSciences position entry and exit signals to maximize returns.
Precision BioSciences Return and Market Media
The median price of Precision BioSciences for the period between Fri, Jan 26, 2024 and Thu, Apr 25, 2024 is 12.0 with a coefficient of variation of 14.06. The daily time series for the period is distributed with a sample standard deviation of 1.75, arithmetic mean of 12.48, and mean deviation of 1.29. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Precision BioSciences Announces Non-Exclusive Patent License Agreement with Caribou Biosciences | 02/20/2024 |
2 | iECURE Secures Approval from U.K. Medicines Healthcare Products Regulatory Agency to Expand the OTC-HOPE Study of ECUR-506 | 03/06/2024 |
3 | Precision BioSciences Presents Preclinical Data Highlighting PBGENE-PMM as a Potential Therapy for Primary Mitochondrial Myopathy | 03/19/2024 |
4 | Acquisition by John Kelly of 20000 shares of Precision BioSciences at 0.86 subject to Rule 16b-3 | 03/22/2024 |
5 | DTIL Stock Earnings Precision BioSciences Misses EPS, Misses Revenue for Q4 2023 | 03/27/2024 |
6 | What is the Markets View on Precision BioSciences Inc Stocks Price and Volume Trends Thursday - InvestorsObserver | 03/28/2024 |
7 | Wall Street Analysts Predict a 407.94 percent Upside in Precision BioSciences Heres What You Should Know | 04/02/2024 |
8 | Precision BioSciences, Inc. Revenue Breakdown NASDAQDTIL TradingView - TradingView | 04/10/2024 |
9 | Precision BioSciences, Inc. Short Interest Up 62.3 percent in March - MarketBeat | 04/12/2024 |
10 | Eli Lilly subsidiary ends lucrative collaboration with Durham biotech | 04/18/2024 |
About Precision BioSciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Precision or other stocks. Alpha measures the amount that position in Precision BioSciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2010 | 2023 | 2024 (projected) | Payables Turnover | 7.35 | 2.78 | 2.64 | Days Of Inventory On Hand | 306.14 | 275.53 | 244.91 |
Precision BioSciences Upcoming Company Events
As portrayed in its financial statements, the presentation of Precision BioSciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Precision BioSciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Precision BioSciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Precision BioSciences. Please utilize our Beneish M Score to check the likelihood of Precision BioSciences' management manipulating its earnings.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Precision BioSciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Precision BioSciences Backtesting, Precision BioSciences Valuation, Precision BioSciences Correlation, Precision BioSciences Hype Analysis, Precision BioSciences Volatility, Precision BioSciences History and analyze Precision BioSciences Performance. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Precision Stock analysis
When running Precision BioSciences' price analysis, check to measure Precision BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Precision BioSciences is operating at the current time. Most of Precision BioSciences' value examination focuses on studying past and present price action to predict the probability of Precision BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Precision BioSciences' price. Additionally, you may evaluate how the addition of Precision BioSciences to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |
Precision BioSciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.